(Q28270899)
Statements
A humanized HLA-DR antibody (hu1D10, apolizumab) in combination with granulocyte colony-stimulating factor (filgrastim) for the treatment of non-Hodgkin's lymphoma: a pilot study (English)
Juergen Rech
Roland Repp
Dorit Rech
Bernhard Stockmeyer
Michael Dechant
Martin Gramatzki
Thomas Valerius
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference